Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: tool dude who wrote (81423)	11/7/2002 1:38:22 PM
From: backman	Read Replies (2) \| Respond to of 122087

thanx, tool...hope you didnt get hurt on ARIA....watching OSUR for possible play tomorrow 13:08 ET OSUR OraSure Tech receives FDA approval for Rapid HIV-1 Antibody Test (6.35 +0.57) OraQuick is the first FDA-approved rapid, point-of-care test designed to detect antibodies to HIV-1 within approx 20 minutes. The FDA approval is based on clinical data submitted by OraSure indicating that the OraQuick test had sensitivity of 99.6% and specificity of 100% in the clinical studies performed with finger-stick whole blood specimens.